메뉴 건너뛰기




Volumn 27, Issue 11, 2010, Pages 785-795

Improving medication compliance in patients with depression: Use of orodispersible tablets

Author keywords

Compliance; Major depressive disorder; Swallowing difficulties

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ARIPIPRAZOLE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; CLOZAPINE; DIAZEPAM; DONEPEZIL; ESCITALOPRAM; KETOPROFEN; LAMOTRIGINE; LANSOPRAZOLE; MIRTAZAPINE; OLANZAPINE; OXAZEPAM; PERPHENAZINE; PIROXICAM; RISPERIDONE; SELEGILINE; SERTRALINE; SUMATRIPTAN; VALPROIC ACID; VENLAFAXINE; VOGLIBOSE; ZOLMITRIPTAN;

EID: 78649331259     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12325-010-0073-y     Document Type: Review
Times cited : (30)

References (55)
  • 2
    • 0022870171 scopus 로고
    • Noncompliance in schizophrenia
    • 1:STN:280:DyaL2s3gsVSrsA%3D%3D 2883650
    • I.E. Babiker 1986 Noncompliance in schizophrenia Psychiatr Dev. 4 329 337 1:STN:280:DyaL2s3gsVSrsA%3D%3D 2883650
    • (1986) Psychiatr Dev. , vol.4 , pp. 329-337
    • Babiker, I.E.1
  • 3
    • 0036773689 scopus 로고    scopus 로고
    • Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature
    • 12416599
    • J.P. Lacro L.B. Dunn C.R. Dolder S.G. Leckband D.V. Jeste 2002 Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature J Clin Psychiatry 63 892 909 12416599
    • (2002) J Clin Psychiatry , vol.63 , pp. 892-909
    • Lacro, J.P.1    Dunn, L.B.2    Dolder, C.R.3    Leckband, S.G.4    Jeste, D.V.5
  • 4
    • 0033950999 scopus 로고    scopus 로고
    • Predicting medication noncompliance after hospital discharge among patients with schizophrenia
    • DOI 10.1176/appi.ps.51.2.216
    • M. Olfson D. Mechanic S. Hansell C.A. Boyer J. Walkup P.J. Weiden 2000 Predicting medication noncompliance after hospital discharge among patients with schizophrenia Psychiatr Serv. 51 216 222 1:STN:280:DC%2BD3c7itFSjtg%3D%3D 10.1176/appi.ps.51.2.216 10655006 (Pubitemid 30082525)
    • (2000) Psychiatric Services , vol.51 , Issue.2 , pp. 216-222
    • Olfson, M.1    Mechanic, D.2    Hansell, S.3    Boyer, C.A.4    Walkup, J.5    Weiden, P.J.6
  • 5
    • 0034710203 scopus 로고    scopus 로고
    • Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence
    • 1:STN:280:DC%2BD3czptVKgug%3D%3D 10.1001/archinte.160.14.2101 10904452
    • M.R. DiMatteo H.S. Lepper T.W. Croghan 2000 Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence Arch Intern Med. 160 2101 2107 1:STN:280:DC%2BD3czptVKgug%3D%3D 10.1001/archinte.160.14.2101 10904452
    • (2000) Arch Intern Med. , vol.160 , pp. 2101-2107
    • Dimatteo, M.R.1    Lepper, H.S.2    Croghan, T.W.3
  • 6
    • 67650034173 scopus 로고    scopus 로고
    • Persistence and compliance to antidepressant treatment in patients with depression: A chart review
    • 10.1186/1471-244X-9-38 19531229
    • N. Sawada H. Uchida T. Suzuki 2009 Persistence and compliance to antidepressant treatment in patients with depression: A chart review BMC Psychiatry 9 38 10.1186/1471-244X-9-38 19531229
    • (2009) BMC Psychiatry , vol.9 , pp. 38
    • Sawada, N.1    Uchida, H.2    Suzuki, T.3
  • 7
    • 34247572943 scopus 로고    scopus 로고
    • Adherence to antidepressant treatment among privately insured patients with depression
    • 10.1097/01.mlr.0000254574.23418.f6 17496721
    • A. Akincigil J.R. Bowblis C. Levin J.T. Walkup S. Jan S. Crystal 2007 Adherence to antidepressant treatment among privately insured patients with depression Med Care 45 363 369 10.1097/01.mlr.0000254574.23418.f6 17496721
    • (2007) Med Care , vol.45 , pp. 363-369
    • Akincigil, A.1    Bowblis, J.R.2    Levin, C.3    Walkup, J.T.4    Jan, S.5    Crystal, S.6
  • 8
    • 33645985828 scopus 로고    scopus 로고
    • Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes
    • DOI 10.1097/01.mlr.0000204287.82701.9b, PII 0000565020060400000002
    • C.R. Cantrell M.T. Eaddy M.B. Shah T.S. Regan M.C. Sokol 2006 Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes Med Care 44 300 303 10.1097/01.mlr. 0000204287.82701.9b 16565629 (Pubitemid 43755432)
    • (2006) Medical Care , vol.44 , Issue.4 , pp. 300-303
    • Cantrell, C.R.1    Eaddy, M.T.2    Shah, M.B.3    Regan, T.S.4    Sokol, M.C.5
  • 10
    • 0035676124 scopus 로고    scopus 로고
    • Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors
    • DOI 10.1192/bjp.179.6.519
    • W.E. Meijer M.L. Bouvy E.R. Heerdink J. Urquhart H.G. Leufkens 2001 Spontaneous lapses in dosing during chronic treatment with selective serotonin reuptake inhibitors Br J Psychiatry 179 519 522 1:STN:280: DC%2BD38%2FgtVOltw%3D%3D 10.1192/bjp.179.6.519 11731355 (Pubitemid 34031677)
    • (2001) British Journal of Psychiatry , vol.179 , Issue.DEC. , pp. 519-522
    • Meijer, W.E.E.1    Bouvy, M.L.2    Heerdink, E.R.3    Urquhart, J.4    Leufkens, H.G.M.5
  • 11
    • 37349059292 scopus 로고    scopus 로고
    • Six-month compliance with antidepressant medication in the treatment of major depressive disorder
    • DOI 10.1097/YIC.0b013e3282f1c1d8, PII 0000485020080100000005
    • K. Demyttenaere A. Adelin P. Mesters W. Dewé K. De Bruyckere 2008 Six-month compliance with antidepressant medication in the treatment of major depressive disorder Int Clin Psychopharmacol. 23 36 42 10.1097/YIC. 0b013e3282f1c1d8 18090506 (Pubitemid 350294868)
    • (2008) International Clinical Psychopharmacology , vol.23 , Issue.1 , pp. 36-42
    • Demyttenaere, K.1    Adelin, A.2    Patrick, M.3    Walthere, D.4    Katrien, D.B.5    Michele, S.6
  • 12
    • 0029192252 scopus 로고
    • The role of the primary care physician in patients' adherence to antidepressant therapy
    • 1:STN:280:DyaK2M7itl2qug%3D%3D 10.1097/00005650-199501000-00006 7823648
    • E.H. Lin M. Von Korff W. Katon 1995 The role of the primary care physician in patients' adherence to antidepressant therapy Med Care 33 67 74 1:STN:280:DyaK2M7itl2qug%3D%3D 10.1097/00005650-199501000-00006 7823648
    • (1995) Med Care , vol.33 , pp. 67-74
    • Lin, E.H.1    Von Korff, M.2    Katon, W.3
  • 13
    • 77955451250 scopus 로고    scopus 로고
    • A review of the costs associated with depression and treatment noncompliance: The potential benefits of online support
    • 10.1097/YIC.0b013e328339fbcf 20715299
    • A. Wade J. Häring 2010 A review of the costs associated with depression and treatment noncompliance: The potential benefits of online support Int Clin Psychopharmacol. 25 288 296 10.1097/YIC.0b013e328339fbcf 20715299
    • (2010) Int Clin Psychopharmacol. , vol.25 , pp. 288-296
    • Wade, A.1    Häring, J.2
  • 14
    • 41549105366 scopus 로고    scopus 로고
    • Factors affecting therapeutic compliance: A review from the patient's perspective
    • 18728716
    • J. Jin G.E. Sklar V.M.S. Oh S.C. Li 2008 Factors affecting therapeutic compliance: A review from the patient's perspective Ther Clin Risk Manag. 4 269 286 18728716
    • (2008) Ther Clin Risk Manag. , vol.4 , pp. 269-286
    • Jin, J.1    Sklar, G.E.2    Oh, V.M.S.3    Li, S.C.4
  • 15
    • 77957128916 scopus 로고    scopus 로고
    • Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease
    • 10.1093/jpepsy/jsp126 20026567
    • K.A. Hommel R.N. Baldassano 2010 Brief report: Barriers to treatment adherence in pediatric inflammatory bowel disease J Pediatr Psychol. 35 1005 1010 10.1093/jpepsy/jsp126 20026567
    • (2010) J Pediatr Psychol. , vol.35 , pp. 1005-1010
    • Hommel, K.A.1    Baldassano, R.N.2
  • 16
    • 35949002894 scopus 로고    scopus 로고
    • Patients' beliefs about depression and how they relate to duration of antidepressant treatment. Use of a US measurement in a UK primary care population
    • J. Lynch T. Kendrick M. Moore O. Johnston P.W.F. Smith 2006 Patients' beliefs about depression and how they relate to duration of antidepressant treatment. Use of a US measurement in a UK primary care population Primary Care Mental Health 4 207 217
    • (2006) Primary Care Mental Health , vol.4 , pp. 207-217
    • Lynch, J.1    Kendrick, T.2    Moore, M.3    Johnston, O.4    Smith, P.W.F.5
  • 17
    • 0035185660 scopus 로고    scopus 로고
    • Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence
    • DOI 10.1176/appi.ps.52.12.1615
    • J.A. Sirey M.L. Bruce G.S. Alexopoulos D.A. Perlick S.J. Friedman B.S. Meyers 2001 Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence Psychiatr Serv. 52 1615 1620 1:STN:280:DC%2BD3MnotVygsQ%3D%3D 10.1176/appi.ps.52.12.1615 11726752 (Pubitemid 33104454)
    • (2001) Psychiatric Services , vol.52 , Issue.12 , pp. 1615-1620
    • Sirey, J.A.1    Bruce, M.L.2    Alexopoulos, G.S.3    Perlick, D.A.4    Friedman, S.J.5    Meyers, B.S.6
  • 18
    • 78649324680 scopus 로고    scopus 로고
    • Society for the Advancement of Education
    • USA Today
    • Society for the Advancement of Education. Swallowing difficulties cause for concern. USA Today. 2004 Oct. Available at: http://findarticles.com/p/ articles/mi-m1272/is-2713-133/ai-n6237884/. Accessed March 12, 2010.
    • Swallowing Difficulties Cause for Concern
  • 20
    • 78649332965 scopus 로고    scopus 로고
    • Head and neck disorders affecting swallowing
    • McCulloch TM, Jaffe D. Head and neck disorders affecting swallowing. GI Motility online; 2006. Available at: http://www.nature.com/gimo/contents/pt1/ full/gimo36.html Accessed August 11, 2010.
    • (2006) GI Motility Online
    • McCulloch, T.M.1    Jaffe, D.2
  • 21
    • 0025942085 scopus 로고
    • Errors of deglutition - Real and imagined; Or, don't forget the psyche
    • 1:STN:280:DyaK38%2FptF2nsA%3D%3D 10.1017/S0022215100117414 1753188
    • J.S. Gilbody 1991 Errors of deglutition - real and imagined; or, don't forget the psyche J Laryngol Otol. 105 807 811 1:STN:280:DyaK38%2FptF2nsA%3D%3D 10.1017/S0022215100117414 1753188
    • (1991) J Laryngol Otol. , vol.105 , pp. 807-811
    • Gilbody, J.S.1
  • 22
    • 0030112520 scopus 로고    scopus 로고
    • Dysphagia and emotional distress
    • 1:STN:280:DyaK2s3msVSqug%3D%3D 9109970
    • O. Bretan M.A. Henry F. [. Kerr-Corrêa 1996 Dysphagia and emotional distress Arq Gastroenterol. 33 60 65 1:STN:280:DyaK2s3msVSqug%3D%3D 9109970
    • (1996) Arq Gastroenterol. , vol.33 , pp. 60-65
    • Bretan, O.1    Henry, M.A.2    Kerr-Corrêa, F.3
  • 23
    • 0034748851 scopus 로고    scopus 로고
    • Patients' evaluation of shape, size and colour of solid dosage forms
    • DOI 10.1023/A:1012050931018
    • A.B. Overgaard J. Hojsted R. Hansen J. Moller-Sonnergaard L.L. Christup 2001 Patients' evaluation of shape, size and colour of solid dosage forms Pharm World Sci. 23 185 188 1:STN:280:DC%2BD3Mnns1agsw%3D%3D 10.1023/A:1012050931018 11721676 (Pubitemid 33027102)
    • (2001) Pharmacy World and Science , vol.23 , Issue.5 , pp. 185-188
    • Overgaard, A.B.A.1    Moller-Sonnergaard, J.2    Christrup, L.L.3    Hojsted, J.4    Hansen, R.5
  • 24
    • 0037014375 scopus 로고    scopus 로고
    • Medication administration in nursing homes
    • 12216309
    • D. Wright 2002 Medication administration in nursing homes Nurs Stand. 16 33 38 12216309
    • (2002) Nurs Stand. , vol.16 , pp. 33-38
    • Wright, D.1
  • 25
    • 33746095382 scopus 로고    scopus 로고
    • Prevalence of dysphagia in acute and community mental health settings
    • DOI 10.1007/s00455-006-9016-9
    • J. Regan R. Sowman I. Walsh 2006 Prevalence of dysphagia in acute and community mental health settings Dysphagia 21 95 101 1:STN:280: DC%2BD28vntFSqug%3D%3D 10.1007/s00455-006-9016-9 16763936 (Pubitemid 44078541)
    • (2006) Dysphagia , vol.21 , Issue.2 , pp. 95-101
    • Regan, J.1    Sowman, R.2    Walsh, I.3
  • 26
    • 34249293341 scopus 로고    scopus 로고
    • The patient-physician relationship in the approach to therapeutic management
    • DOI 10.1007/s10072-007-0765-5
    • G.C. Manzoni P. Torelli 2007 The patient-physician relationship in the approach to therapeutic management Neurol Sci. 28 suppl.2 S130 S133 10.1007/s10072-007-0765-5 17508159 (Pubitemid 46813641)
    • (2007) Neurological Sciences , vol.28 , Issue.SUPPL. 2
    • Manzoni, G.C.1    Torelli, P.2
  • 27
    • 18744386141 scopus 로고    scopus 로고
    • Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies
    • DOI 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10
    • Y. Fu Y. Schicheng S.H. Jeong S. Kimura K. Park 2004 Orally fast disintegrating tablets: Developments, technologies, taste-masking and clinical studies Crit Rev Ther Drug Carrier Syst. 21 433 475 1:CAS:528: DC%2BD2MXltlWgsbs%3D 10.1615/CritRevTherDrugCarrierSyst.v21.i6.10 15658933 (Pubitemid 41647575)
    • (2004) Critical Reviews in Therapeutic Drug Carrier Systems , vol.21 , Issue.6 , pp. 433-475
    • Fu, Y.1    Yang, S.2    Jeong, S.H.3    Kimura, S.4    Park, K.5
  • 28
    • 72749112604 scopus 로고    scopus 로고
    • Formulation design and optimization of fast dissolving clonazepam tablets
    • 1:STN:280:DC%2BC3czmsVeqsA%3D%3D 10.4103/0250-474X.58189 20502581
    • S.B. Shirsand S. Suresh O.V. Swamy 2009 Formulation design and optimization of fast dissolving clonazepam tablets Indian J Pharm Sci. 71 567 572 1:STN:280:DC%2BC3czmsVeqsA%3D%3D 10.4103/0250-474X.58189 20502581
    • (2009) Indian J Pharm Sci. , vol.71 , pp. 567-572
    • Shirsand, S.B.1    Suresh, S.2    Swamy, O.V.3
  • 29
    • 34249301019 scopus 로고    scopus 로고
    • Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet
    • DOI 10.1080/03639040601150237, PII 778978621
    • I.S. Ahmed F.A. Fatahalla 2007 Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet Drug Dev Ind Pharm. 33 505 511 1:CAS:528:DC%2BD2sXlsFChsrY%3D 10.1080/ 03639040601150237 17520441 (Pubitemid 46808770)
    • (2007) Drug Development and Industrial Pharmacy , vol.33 , Issue.5 , pp. 505-511
    • Ahmed, I.S.1    Fatahalla, F.A.2
  • 30
    • 17644384451 scopus 로고    scopus 로고
    • Pharmacokinetic profiles of two tablet formulations of piroxicam
    • DOI 10.1016/j.ijpharm.2005.02.006
    • C. Rasetti-Escargueil V. Grangé 2005 Pharmacokinetic profiles of two tablet formulations of piroxicam Int J Pharm. 296 129 134 10.1016/j.ijpharm.2005.02.006 (Pubitemid 40558796)
    • (2005) International Journal of Pharmaceutics , vol.295 , Issue.1-2 , pp. 129-134
    • Rasetti-Escargueil, C.1    Grange, V.2
  • 31
  • 32
    • 0018840433 scopus 로고
    • Fear of choking and its treatment. A behavioural approach
    • 1:STN:280:DyaL3c7ns1OjtA%3D%3D 6102887
    • L. Solyom D. Sookman 1980 Fear of choking and its treatment. A behavioural approach Can J Psychiatry 25 30 34 1:STN:280:DyaL3c7ns1OjtA%3D%3D 6102887
    • (1980) Can J Psychiatry , vol.25 , pp. 30-34
    • Solyom, L.1    Sookman, D.2
  • 33
    • 70349861743 scopus 로고    scopus 로고
    • Choking phobia: Full remission following behavior therapy
    • 10.1590/S1516-44462009005000002 19787155
    • S. Scemes R.C. Wielenska M.A. Savoia M. Bernik 2009 Choking phobia: Full remission following behavior therapy Rev Bras Psiquiatr. 31 257 260 10.1590/S1516-44462009005000002 19787155
    • (2009) Rev Bras Psiquiatr. , vol.31 , pp. 257-260
    • Scemes, S.1    Wielenska, R.C.2    Savoia, M.A.3    Bernik, M.4
  • 34
    • 78649335316 scopus 로고    scopus 로고
    • Difficult to swallow: Patient preferences for alternative valproate pharmaceutical formulations
    • 10.2147/PPA.S5691 19936158
    • M. Bhosle J.S. Benner M. DeKoven J. Shelton 2009 Difficult to swallow: Patient preferences for alternative valproate pharmaceutical formulations Patient Prefer Adherence 3 161 171 10.2147/PPA.S5691 19936158
    • (2009) Patient Prefer Adherence , vol.3 , pp. 161-171
    • Bhosle, M.1    Benner, J.S.2    Dekoven, M.3    Shelton, J.4
  • 35
    • 23844462862 scopus 로고    scopus 로고
    • Part IV: Effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: A post-marketing surveillance study in Germany
    • DOI 10.1185/030079905X46296
    • H.C. Diener A. Gendolla 2005 Part IV: Effects of zolmitriptan orally disintegrating tablet on migraine symptoms and ability to perform normal activities: A postmarketing surveillance study in Germany Curr Med Res Opin. 21 suppl.3 S18 24 1:CAS:528:DC%2BD2MXhtFKktbzO 10.1185/030079905X46296 16083520 (Pubitemid 41152959)
    • (2005) Current Medical Research and Opinion, Supplement , vol.21 , Issue.3
    • Diener, H.-C.1    Gendolla, A.2
  • 36
    • 0141725778 scopus 로고    scopus 로고
    • Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet
    • 1:CAS:528:DC%2BD3sXotl2jsb4%3D 14529055
    • A.J. Dowson B.R. Charlesworth 2003 Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet Int J Clin Pract. 57 573 576 1:CAS:528:DC%2BD3sXotl2jsb4%3D 14529055
    • (2003) Int J Clin Pract. , vol.57 , pp. 573-576
    • Dowson, A.J.1    Charlesworth, B.R.2
  • 37
    • 34948889170 scopus 로고    scopus 로고
    • Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease: ACCEPTO study
    • 10.2165/00044011-200727110-00003 17914895
    • C.M. de Argila J. Ponce E. Márquez 2007 Acceptability of lansoprazole orally disintegrating tablets in patients with gastro-oesophageal reflux disease: ACCEPTO study Clin Drug Investig. 27 765 770 10.2165/00044011-200727110-00003 17914895
    • (2007) Clin Drug Investig. , vol.27 , pp. 765-770
    • De Argila, C.M.1    Ponce, J.2    Márquez, E.3
  • 38
    • 67650090764 scopus 로고    scopus 로고
    • A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS study
    • 1:STN:280:DC%2BD1MvotFSjtw%3D%3D 10.1016/j.schres.2009.05.024 19535229
    • J. Karagianis L. Grossman J. Landry 2009 A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS study Schizophr Res. 113 41 48 1:STN:280:DC%2BD1MvotFSjtw%3D%3D 10.1016/j.schres.2009.05.024 19535229
    • (2009) Schizophr Res. , vol.113 , pp. 41-48
    • Karagianis, J.1    Grossman, L.2    Landry, J.3
  • 39
    • 59849119668 scopus 로고    scopus 로고
    • Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet
    • 10.1620/tjem.216.249 18987459
    • N. Koh S. Sakamoto F. Chino 2008 Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet Tohoku J Exp Med. 216 249 257 10.1620/tjem.216.249 18987459
    • (2008) Tohoku J Exp Med. , vol.216 , pp. 249-257
    • Koh, N.1    Sakamoto, S.2    Chino, F.3
  • 41
    • 49849089222 scopus 로고    scopus 로고
    • Olanzapine orally disintegrating tablet: A review of efficacy and compliance
    • 1:CAS:528:DC%2BD1cXhtFentLvK 10.1111/j.1755-5949.2008.00053.x 18801113
    • L. San M. Csillas A. Ciudad I. Gilaberte 2008 Olanzapine orally disintegrating tablet: A review of efficacy and compliance CNS Neurosci Ther. 14 203 214 1:CAS:528:DC%2BD1cXhtFentLvK 10.1111/j.1755-5949.2008.00053.x 18801113
    • (2008) CNS Neurosci Ther. , vol.14 , pp. 203-214
    • San, L.1    Csillas, M.2    Ciudad, A.3    Gilaberte, I.4
  • 43
    • 34447498650 scopus 로고    scopus 로고
    • Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia [1]
    • DOI 10.1097/01.jcp.0000264986.32733.df, PII 0000471420070800000012
    • H. Lieu-Seifert J. Houston D. Adams B.J. Kinon 2007 Association of acute symptoms and compliance attitude in noncompliant patients with schizophrenia J Clin Psychopharmacol. 27 392 394 10.1097/01.jcp.0000264986.32733.df (Pubitemid 47075511)
    • (2007) Journal of Clinical Psychopharmacology , vol.27 , Issue.4 , pp. 392-394
    • Liu-Seifert, H.1    Houston, J.P.2    Adams, D.H.3    Kinon, B.J.4
  • 44
    • 33748299609 scopus 로고    scopus 로고
    • Improving medication adherence with orally disintegrating tablets
    • 16951598
    • G. Uko-Ekpenyong 2006 Improving medication adherence with orally disintegrating tablets Nursing 36 20 21 16951598
    • (2006) Nursing , vol.36 , pp. 20-21
    • Uko-Ekpenyong, G.1
  • 45
    • 28844435374 scopus 로고    scopus 로고
    • Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia
    • 10.4088/JCP.v66n1121e 16420093
    • F.L. Tornatore 2005 Orally disintegrating antipsychotics may promote compliance and adherence in patients with schizophrenia J Clin Psychiatry 66 1493 1494 10.4088/JCP.v66n1121e 16420093
    • (2005) J Clin Psychiatry , vol.66 , pp. 1493-1494
    • Tornatore, F.L.1
  • 46
    • 33845419519 scopus 로고    scopus 로고
    • Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets
    • DOI 10.1055/s-2006-950498
    • C. Normann M. Schmauss N. Bakri M. Gerwe A. Schreiner 2006 Initial treatment of severe acute psychosis with fast orally disintegrating risperidone tablets Pharmacopsychiatry 39 209 212 1:CAS:528:DC%2BD2sXhs1yqtr0%3D 10.1055/s-2006-950498 17124642 (Pubitemid 44899721)
    • (2006) Pharmacopsychiatry , vol.39 , Issue.6 , pp. 209-212
    • Normann, C.1    Schmauss, M.2    Bakri, N.3    Gerwe, M.4    Schreiner, A.5
  • 48
    • 0344413673 scopus 로고    scopus 로고
    • Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home
    • DOI 10.1185/030079903125002441
    • S.P. Roose J.C. Nelson C. Salzman S.B. Hollander H. f. t. Rodrigues Mirtazapine in the Nursing Home Study Group 2003 Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home Curr Med Res Opin. 19 737 746 10.1185/030079903125002441 14687445 (Pubitemid 37466144)
    • (2003) Current Medical Research and Opinion , vol.19 , Issue.8 , pp. 737-746
    • Roose, S.P.1    Nelson, J.C.2    Salzman, C.3    Hollander, S.B.4    Rodrigues, H.5
  • 50
    • 31544450244 scopus 로고    scopus 로고
    • Mirtazapine orally disintegrating tablets versus venlafaxine extended release: A double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder
    • DOI 10.1097/01.jcp.0000194622.99986.d6
    • O. Benkert A. Szegedi M. Philipp 2006 Mirtazapine orally disintegrating tablets versus venlafaxine extended release: A double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder J Clin Psychopharmacol. 26 75 78 1:CAS:528:DC%2BD28XhsFGhtr0%3D 10.1097/01.jcp.0000194622.99986.d6 16415711 (Pubitemid 43167095)
    • (2006) Journal of Clinical Psychopharmacology , vol.26 , Issue.1 , pp. 75-78
    • Benkert, O.1    Szegedi, A.2    Philipp, M.3    Kohnen, R.4    Heinrich, C.5    Heukels, A.6    Van Der Vegte-Senden, M.7    Baker, R.A.8    Simmons, J.H.9    Schutte, A.-J.10
  • 51
    • 67249134483 scopus 로고    scopus 로고
    • Treating depression with different galenical drug formulations: Does it make a difference? the comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT)
    • 1:CAS:528:DC%2BD1MXlslChsb0%3D 10.1080/13651500802485262
    • A. Delini-Stula H. van Oers A. van Willigenburg B. Oddens A.-J. Schutte E. van der Meulen 2009 Treating depression with different galenical drug formulations: Does it make a difference? The comparison of mirtazapine fast dissolving formulation (FDT) with conventional mirtazapine tablets (CT) Int J Psychiatry Clin Pract. 13 109 116 1:CAS:528:DC%2BD1MXlslChsb0%3D 10.1080/13651500802485262
    • (2009) Int J Psychiatry Clin Pract. , vol.13 , pp. 109-116
    • Delini-Stula, A.1    Van Oers, H.2    Van Willigenburg, A.3    Oddens, B.4    Schutte, A.-J.5    Van Der Meulen, E.6
  • 52
    • 33745096263 scopus 로고    scopus 로고
    • The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients
    • DOI 10.1080/13651500600579175, PII G34176288737
    • A. Delini-Stula R. Bischof 2006 The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients Int J Psychiatry Clin Pract. 10 124 130 1:CAS:528:DC%2BD28XmvV2jsLk%3D 10.1080/13651500600579175 (Pubitemid 43879977)
    • (2006) International Journal of Psychiatry in Clinical Practice , vol.10 , Issue.2 , pp. 124-130
    • Delini-Stula, A.1    Bischof, R.2
  • 54
    • 64349093528 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors
    • S.H. Preskorn H.P. Feighner C.Y. Stanga R. Ross (eds). Springer Berlin
    • Preskorn SH, Ross R, Stanga CY. Selective serotonin reuptake inhibitors. In: Preskorn SH, Feighner HP, Stanga CY, Ross R, editors. Antidepressants: Past, present and future. Berlin: Springer; 2004; 241-262.
    • (2004) Antidepressants: Past, Present and Future , pp. 241-262
    • Preskorn, S.H.1    Ross, R.2    Stanga, C.Y.3
  • 55
    • 60849086169 scopus 로고    scopus 로고
    • Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple treatment meta-analysis
    • 1:CAS:528:DC%2BD1MXisVOrtr8%3D 10.1016/S0140-6736(09)60046-5 19185342
    • A. Cipriani T.A. Furukawa G. Salanti 2009 Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple treatment meta-analysis Lancet 373 746 758 1:CAS:528:DC%2BD1MXisVOrtr8%3D 10.1016/S0140-6736(09)60046-5 19185342
    • (2009) Lancet , vol.373 , pp. 746-758
    • Cipriani, A.1    Furukawa, T.A.2    Salanti, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.